Suppr超能文献

心房颤动与癌症——流行病学、机制及管理

Atrial Fibrillation and Cancer-Epidemiology, Mechanisms, and Management.

作者信息

Davis Nathaniel E, Prasitlumkum Narut, Tan Nicholas Y

机构信息

Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

J Clin Med. 2024 Dec 19;13(24):7753. doi: 10.3390/jcm13247753.

Abstract

Atrial fibrillation (AF) and cancer are increasingly recognized as interrelated conditions, with cancer patients showing elevated incidences of AF, and there is evidence that AF may sometimes precede cancer diagnoses. This comprehensive review investigates the epidemiology, pathophysiology, and management challenges associated with AF in cancer patients. Epidemiologically, several cancers are more closely related to increased rates of AF, including lung, colorectal, gastrointestinal, and hematologic malignancies. Mechanistically, both AF and cancer share pathophysiological pathways centered on inflammation, oxidative stress, and common cardiovascular risk factors, such as hypertension, obesity, and diabetes. The inflammatory microenvironment in tumors, marked by increased cytokines and growth factors, promotes atrial remodeling and AF susceptibility. Elevated reactive oxygen species (ROS) levels, driven by the metabolic demands of cancer, further contribute to atrial fibrosis and structural changes. Moreover, many anticancer treatments exacerbate AF risk. Management of AF in cancer patients presents many unique challenges and requires a multidisciplinary approach. Rate and rhythm control strategies are complicated by potential drug-drug interactions and limited data surrounding early implementation of rhythm control strategies in cancer patients. Interventional approaches such as catheter ablation, though effective in maintaining sinus rhythm, carry significant perioperative risk in patients with malignancy. Stroke prevention with anticoagulants is essential but requires cautious administration to avoid heightened bleeding risks, particularly in patients undergoing chemotherapy. Further, the limited applicability of standard risk stratification tools like CHA2DS2-VASc in this population complicate decisions regarding anticoagulation. This review highlights the bidirectional relationship between AF and cancer, the difficulties in management, and the critical need for further research in this field.

摘要

心房颤动(AF)与癌症越来越被认为是相互关联的疾病,癌症患者的AF发病率升高,并且有证据表明AF有时可能先于癌症诊断出现。这篇综述全面调查了癌症患者中与AF相关的流行病学、病理生理学及管理挑战。在流行病学方面,几种癌症与AF发病率增加的关系更为密切,包括肺癌、结直肠癌、胃肠道癌和血液系统恶性肿瘤。在发病机制上,AF和癌症都有以炎症、氧化应激以及高血压、肥胖和糖尿病等常见心血管危险因素为中心的病理生理途径。肿瘤中的炎症微环境以细胞因子和生长因子增加为特征,促进心房重塑和AF易感性。由癌症代谢需求驱动的活性氧(ROS)水平升高,进一步导致心房纤维化和结构改变。此外,许多抗癌治疗会加剧AF风险。癌症患者的AF管理存在许多独特挑战,需要多学科方法。心率和节律控制策略因潜在的药物相互作用以及癌症患者早期实施节律控制策略的相关数据有限而变得复杂。诸如导管消融等介入方法虽然在维持窦性心律方面有效,但在恶性肿瘤患者中具有重大围手术期风险。使用抗凝剂预防中风至关重要,但需要谨慎给药以避免出血风险增加,尤其是在接受化疗的患者中。此外,CHA2DS2-VASc等标准风险分层工具在该人群中的适用性有限,使抗凝决策变得复杂。这篇综述强调了AF与癌症之间的双向关系、管理中的困难以及该领域进一步研究的迫切需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eda/11677472/321c2c84d9b4/jcm-13-07753-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验